vs
Mistras Group, Inc.（MG）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Mistras Group, Inc.的1.1倍（$197.9M vs $181.5M），REPLIGEN CORP净利率更高（6.7% vs 2.1%，领先4.6%），REPLIGEN CORP同比增速更快（13.6% vs 5.1%），Mistras Group, Inc.自由现金流更多（$26.0M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -0.8%）
Mistras集团是全球资产完整性与保护解决方案供应商，主营无损检测、工业实时监测、工程咨询等服务，核心客户覆盖油气、航空航天、发电、制造等领域，业务遍及北美、欧洲及亚太地区，可帮助客户提升运营安全性、延长资产寿命、降低非计划停机风险。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
MG vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$181.5M
营收增速更快
RGEN
高出8.6%
5.1%
净利率更高
RGEN
高出4.6%
2.1%
自由现金流更多
MG
多$8.4M
$17.6M
两年增速更快
RGEN
近两年复合增速
-0.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $181.5M | $197.9M |
| 净利润 | $3.8M | $13.3M |
| 毛利率 | 28.4% | 52.5% |
| 营业利润率 | 7.0% | 9.0% |
| 净利率 | 2.1% | 6.7% |
| 营收同比 | 5.1% | 13.6% |
| 净利润同比 | -27.4% | 143.9% |
| 每股收益（稀释后） | $0.12 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MGRGEN
| Q4 25 | $181.5M | $197.9M | ||
| Q3 25 | $195.5M | $188.8M | ||
| Q2 25 | $185.4M | $182.4M | ||
| Q1 25 | $161.6M | $169.2M | ||
| Q4 24 | $172.7M | $174.1M | ||
| Q3 24 | $182.7M | $154.9M | ||
| Q2 24 | $189.8M | $154.1M | ||
| Q1 24 | $184.4M | $151.3M |
净利润MGRGEN
| Q4 25 | $3.8M | $13.3M | ||
| Q3 25 | $13.1M | $14.9M | ||
| Q2 25 | $3.0M | $14.9M | ||
| Q1 25 | $-3.2M | $5.8M | ||
| Q4 24 | $5.2M | $-30.3M | ||
| Q3 24 | $6.4M | $-654.0K | ||
| Q2 24 | $6.4M | $3.3M | ||
| Q1 24 | $995.0K | $2.1M |
毛利率MGRGEN
| Q4 25 | 28.4% | 52.5% | ||
| Q3 25 | 29.8% | 53.2% | ||
| Q2 25 | 29.1% | 50.0% | ||
| Q1 25 | 25.3% | 53.6% | ||
| Q4 24 | 26.5% | 26.1% | ||
| Q3 24 | 26.8% | 50.0% | ||
| Q2 24 | 27.1% | 49.8% | ||
| Q1 24 | 25.0% | 49.5% |
营业利润率MGRGEN
| Q4 25 | 7.0% | 9.0% | ||
| Q3 25 | 10.4% | 8.9% | ||
| Q2 25 | 4.5% | 7.6% | ||
| Q1 25 | -0.6% | 3.9% | ||
| Q4 24 | 6.1% | -17.7% | ||
| Q3 24 | 6.5% | -5.1% | ||
| Q2 24 | 6.3% | 1.0% | ||
| Q1 24 | 3.0% | 1.3% |
净利率MGRGEN
| Q4 25 | 2.1% | 6.7% | ||
| Q3 25 | 6.7% | 7.9% | ||
| Q2 25 | 1.6% | 8.2% | ||
| Q1 25 | -2.0% | 3.4% | ||
| Q4 24 | 3.0% | -17.4% | ||
| Q3 24 | 3.5% | -0.4% | ||
| Q2 24 | 3.4% | 2.2% | ||
| Q1 24 | 0.5% | 1.4% |
每股收益（稀释后）MGRGEN
| Q4 25 | $0.12 | $0.24 | ||
| Q3 25 | $0.41 | $0.26 | ||
| Q2 25 | $0.10 | $0.26 | ||
| Q1 25 | $-0.10 | $0.10 | ||
| Q4 24 | $0.17 | $-0.55 | ||
| Q3 24 | $0.20 | $-0.01 | ||
| Q2 24 | $0.20 | $0.06 | ||
| Q1 24 | $0.03 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.0M | $767.6M |
| 总债务越低越好 | $178.0M | $542.2M |
| 股东权益账面价值 | $235.1M | $2.1B |
| 总资产 | $578.8M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.76× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资MGRGEN
| Q4 25 | $28.0M | $767.6M | ||
| Q3 25 | $27.8M | $748.7M | ||
| Q2 25 | $20.0M | $708.9M | ||
| Q1 25 | $18.5M | $697.2M | ||
| Q4 24 | $18.3M | $757.4M | ||
| Q3 24 | $20.4M | $784.0M | ||
| Q2 24 | $17.2M | $809.1M | ||
| Q1 24 | $16.9M | $780.6M |
总债务MGRGEN
| Q4 25 | $178.0M | $542.2M | ||
| Q3 25 | $202.3M | $537.9M | ||
| Q2 25 | $189.4M | — | ||
| Q1 25 | $171.9M | — | ||
| Q4 24 | $169.6M | $525.6M | ||
| Q3 24 | $189.7M | — | ||
| Q2 24 | $199.7M | — | ||
| Q1 24 | $198.4M | — |
股东权益MGRGEN
| Q4 25 | $235.1M | $2.1B | ||
| Q3 25 | $227.4M | $2.1B | ||
| Q2 25 | $215.8M | $2.1B | ||
| Q1 25 | $198.7M | $2.0B | ||
| Q4 24 | $198.6M | $2.0B | ||
| Q3 24 | $205.2M | $2.0B | ||
| Q2 24 | $193.2M | $2.0B | ||
| Q1 24 | $187.1M | $2.0B |
总资产MGRGEN
| Q4 25 | $578.8M | $2.9B | ||
| Q3 25 | $596.3M | $2.9B | ||
| Q2 25 | $571.0M | $2.9B | ||
| Q1 25 | $526.8M | $2.9B | ||
| Q4 24 | $523.0M | $2.8B | ||
| Q3 24 | $551.7M | $2.8B | ||
| Q2 24 | $548.1M | $2.9B | ||
| Q1 24 | $542.1M | $2.8B |
负债/权益比MGRGEN
| Q4 25 | 0.76× | 0.26× | ||
| Q3 25 | 0.89× | 0.26× | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.87× | — | ||
| Q4 24 | 0.85× | 0.27× | ||
| Q3 24 | 0.92× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | 1.06× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $26.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 14.3% | 8.9% |
| 资本支出强度资本支出/营收 | 3.4% | 4.1% |
| 现金转化率经营现金流/净利润 | 8.55× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $8.3M | $93.9M |
8季度趋势，按日历期对齐
经营现金流MGRGEN
| Q4 25 | $32.1M | $25.7M | ||
| Q3 25 | $4.5M | $48.1M | ||
| Q2 25 | $-9.3M | $28.6M | ||
| Q1 25 | $5.6M | $15.0M | ||
| Q4 24 | $25.7M | $39.2M | ||
| Q3 24 | $19.4M | $49.3M | ||
| Q2 24 | $4.5M | $42.2M | ||
| Q1 24 | $604.0K | $44.7M |
自由现金流MGRGEN
| Q4 25 | $26.0M | $17.6M | ||
| Q3 25 | $-4.1M | $43.4M | ||
| Q2 25 | $-14.7M | $21.5M | ||
| Q1 25 | $1.1M | $11.4M | ||
| Q4 24 | $22.1M | $33.6M | ||
| Q3 24 | $14.6M | $42.3M | ||
| Q2 24 | $-284.0K | $37.4M | ||
| Q1 24 | $-4.2M | $36.4M |
自由现金流率MGRGEN
| Q4 25 | 14.3% | 8.9% | ||
| Q3 25 | -2.1% | 23.0% | ||
| Q2 25 | -7.9% | 11.8% | ||
| Q1 25 | 0.7% | 6.8% | ||
| Q4 24 | 12.8% | 19.3% | ||
| Q3 24 | 8.0% | 27.3% | ||
| Q2 24 | -0.1% | 24.3% | ||
| Q1 24 | -2.3% | 24.0% |
资本支出强度MGRGEN
| Q4 25 | 3.4% | 4.1% | ||
| Q3 25 | 4.4% | 2.5% | ||
| Q2 25 | 2.9% | 3.9% | ||
| Q1 25 | 2.8% | 2.1% | ||
| Q4 24 | 2.1% | 3.2% | ||
| Q3 24 | 2.6% | 4.5% | ||
| Q2 24 | 2.5% | 3.1% | ||
| Q1 24 | 2.6% | 5.5% |
现金转化率MGRGEN
| Q4 25 | 8.55× | 1.93× | ||
| Q3 25 | 0.34× | 3.23× | ||
| Q2 25 | -3.07× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | 4.96× | — | ||
| Q3 24 | 3.02× | — | ||
| Q2 24 | 0.71× | 12.70× | ||
| Q1 24 | 0.61× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
